Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Assess the Effectiveness and Safety of Rivaroxaban in Reducing the Risk of Death, Myocardial Infarction or Stroke in Participants With Heart Failure and Coronary Artery Disease Following an Episode of Decompensated Heart Failure

ClinicalTrials.gov ID: NCT01877915

Public ClinicalTrials.gov record NCT01877915. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 10:30 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Event-driven, Multicenter Study Comparing the Efficacy and Safety of Rivaroxaban With Placebo for Reducing the Risk of Death, Myocardial Infarction or Stroke in Subjects With Heart Failure and Significant Coronary Artery Disease Following an Episode of Decompensated Heart Failure

Study identification

NCT ID
NCT01877915
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Janssen Research & Development, LLC
Industry
Enrollment
5,081 participants

Conditions and interventions

Interventions

  • Rivaroxaban Drug
  • Placebo Drug
  • Standard of care for heart failure and coronary artery disease Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 95 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 9, 2013
Primary completion
Apr 18, 2018
Completion
Apr 18, 2018
Last update posted
May 9, 2019

2013 – 2018

United States locations

U.S. sites
115
U.S. states
37
U.S. cities
115
Facility City State ZIP Site status
Not listed Alexander City Alabama
Not listed Birmingham Alabama
Not listed Mobile Alabama
Not listed Anchorage Alaska
Not listed Tucson Arizona
Not listed Jonesboro Arkansas
Not listed Beverly Hills California
Not listed Chula Vista California
Not listed El Cajon California
Not listed Glendale California
Not listed La Mesa California
Not listed Los Angeles California
Not listed Newport Beach California
Not listed Orange California
Not listed Stockton California
Not listed Torrance California
Not listed Aurora Colorado
Not listed Denver Colorado
Not listed New Haven Connecticut
Not listed Atlantis Florida
Not listed Daytona Beach Florida
Not listed Jupiter Florida
Not listed Orlando Florida
Not listed St. Petersburg Florida
Not listed Tallahassee Florida
Not listed Wellington Florida
Not listed Winter Haven Florida
Not listed Athens Georgia
Not listed Atlanta Georgia
Not listed Cumming Georgia
Not listed Macon Georgia
Not listed Tucker Georgia
Not listed Chicago Illinois
Not listed Evanston Illinois
Not listed Fairview Heights Illinois
Not listed Peoria Illinois
Not listed Rockford Illinois
Not listed Urbana Illinois
Not listed Anderson Indiana
Not listed Indianapolis Indiana
Not listed Merrillville Indiana
Not listed Munster Indiana
Not listed South Bend Indiana
Not listed Iowa City Iowa
Not listed Elizabethtown Kentucky
Not listed Lexington Kentucky
Not listed Louisville Kentucky
Not listed Owensboro Kentucky
Not listed Bossier City Louisiana
Not listed Hammond Louisiana
Not listed Shreveport Louisiana
Not listed Slidell Louisiana
Not listed Biddeford Maine
Not listed Baltimore Maryland
Not listed Columbia Maryland
Not listed Randallstown Maryland
Not listed Bay City Michigan
Not listed Grand Blanc Michigan
Not listed Mount Clemens Michigan
Not listed Pontiac Michigan
Not listed Ypsilanti Michigan
Not listed Saint Paul Minnesota
Not listed Springfield Missouri
Not listed St Louis Missouri
Not listed Washington Missouri
Not listed Lincoln Nebraska
Not listed Las Vegas Nevada
Not listed Bridgewater New Jersey
Not listed Elmer New Jersey
Not listed Haddon Heights New Jersey
Not listed Manalapan New Jersey
Not listed Ridgewood New Jersey
Not listed Sewell New Jersey
Not listed Albuquerque New Mexico
Not listed Buffalo New York
Not listed Cortlandt Manor New York
Not listed Jamaica New York
Not listed Mineola New York
Not listed New York New York
Not listed Charlotte North Carolina
Not listed High Point North Carolina
Not listed Pinehurst North Carolina
Not listed Canton Ohio
Not listed Cincinnati Ohio
Not listed Columbus Ohio
Not listed Dayton Ohio
Not listed Fairfield Ohio
Not listed Kettering Ohio
Not listed Bartlesville Oklahoma
Not listed Oklahoma City Oklahoma
Not listed Tulsa Oklahoma
Not listed Portland Oregon
Not listed Doylestown Pennsylvania
Not listed Philadelphia Pennsylvania
Not listed Sayre Pennsylvania
Not listed Sellersville Pennsylvania
Not listed Wynnewood Pennsylvania
Not listed Yardley Pennsylvania
Not listed York Pennsylvania
Not listed Charleston South Carolina
Not listed Sioux Falls South Dakota
Not listed Nashville Tennessee
Not listed Cypress Texas
Not listed Dallas Texas
Not listed Fort Worth Texas
Not listed Houston Texas
Not listed Huntsville Texas
Not listed Kingwood Texas
Not listed Lubbock Texas
Not listed McKinney Texas
Not listed Burlington Vermont
Not listed Newport News Virginia
Not listed Bellingham Washington
Not listed Tacoma Washington
Not listed Huntington West Virginia

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 448 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01877915, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 9, 2019 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01877915 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →